-+ 0.00%
-+ 0.00%
-+ 0.00%

Keybanc Maintains Overweight on Solventum, Raises Price Target to $102

Benzinga·08/06/2026 14:41:52
Listen to the news
Keybanc analyst Brett Fishbin maintains Solventum (NYSE:SOLV) with a Overweight and raises the price target from $93 to $102.